Factors associated with lower disease‐specific and generic health‐related quality of life in Rome <scp>IV</scp> irritable bowel syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Factors associated with lower disease‐specific and generic health‐related quality of life in Rome IV irritable bowel syndrome

Published:2022-12-21 Issue:3 Volume:57 Page:323-334
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Goodoory Vivek C.¹²^ORCID,Guthrie Elspeth A.³,Ng Cho E.⁴,Black Christopher J.¹²^ORCID,Ford Alexander C.¹²^ORCID

Affiliation:

1. Leeds Institute of Medical Research at St. James's, University of Leeds Leeds UK

2. Leeds Gastroenterology Institute, St. James's University Hospital Leeds UK

3. Leeds Institute of Health Sciences, University of Leeds Leeds UK

4. County Durham and Darlington NHS Foundation Trust Durham UK

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17356

Reference88 articles.

1. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis

2. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study

3. Irritable bowel syndrome

4. Pathophysiology of irritable bowel syndrome

5. ACG Clinical Guideline: Management of Irritable Bowel Syndrome

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concordance between Rome III and Rome IV criteria in irritable bowel syndrome;Indian Journal of Gastroenterology;2024-07-02

2. The gut microbiome in disorders of gut–brain interaction;Gut Microbes;2024-07

3. Novel Irritable Bowel Syndrome Subgroups are Reproducible in the Global Adult Population;Clinical Gastroenterology and Hepatology;2024-06

4. Efficacy and tolerability of chitin-glucan combined with simethicone (GASTRAP^® DIRECT) in irritable bowel syndrome: A prospective, open-label, multicenter study;World Journal of Gastrointestinal Pharmacology and Therapeutics;2024-05-28

5. Postprandial symptoms in disorders of gut-brain interaction and their potential as a treatment target;Gut;2024-05-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3